3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
22
Recurrence
4
Neoplasms
3
Plasmablastic Lymphoma
2
Leukemia, Myeloid, Acute
2
Smoldering Multiple Myeloma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmacytoma
1
Myelodysplastic Syndromes
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Plasma Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Specimen Handling
5
Biopsy
5
Magnetic Resonance Spectroscopy
4
Cyclophosphamide
3
sodium-iodide symporter
2
ruxolitinib
2
duvelisib
2
cemiplimab
2
X-Rays
2
Vincristine
2
Prednisone
2
Photons
2
Immunoglobulin G
2
Etoposide
2
Doxorubicin
2
Disulfides
2
prednylidene
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
Stem Cell Transplantation
1
Standard of Care
1
Practice Guidelines as Topic
1
Peripheral Blood Stem Cell Transplantation
1
Oxaliplatin
1
Nivolumab
1
Melphalan
1
Leukapheresis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell
×
daratumumab
×
30 days
×
Clear all
No trials found.